Atossa Therapeutics Inc. (NASDAQ: ATOS) started the day on December 29, 2021, with a price decrease of -3.61% at $1.60. During the day, the stock rose to $1.67 and sunk to $1.57 before settling in for the price of $1.66 at the close. Taking a more long-term approach, ATOS posted a 52-week range of $0.86-$9.80.
Meanwhile, its Annual Earning per share during the time was 52.40%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 2.70%. This publicly-traded company’s shares outstanding now amounts to $120.82 million. The organization now has a market capitalization sitting at $193.32 million. At the time of writing, stock’s 50-day Moving Average stood at $2.3242, while the 200-day Moving Average is $3.2476.
Atossa Therapeutics Inc. (ATOS) Ownership Facts and Figures
Now let’s turn our focus to how large-scale investors are working with this stock of the Biotechnology Industry. Atossa Therapeutics Inc.’s current insider ownership accounts for 0.04%, in contrast to 27.80% institutional ownership. According to the most recent insider trade that took place on Jul 02, this organization’s Director sold 107,497 shares at the rate of 5.58, making the entire transaction reach 599,833 in total value, affecting insider ownership by 0.
Atossa Therapeutics Inc. (ATOS) Earnings and Revenue Records
In the latest quarterly report released, which was put into the public domain on 9/29/2021, the organization reported -$0.04 earnings per share (EPS) for the three months, surpassing the consensus estimate (set at -$0.04) by $0. This company achieved a return on equity of -88.42. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.06 per share during the current fiscal year.
Atossa Therapeutics Inc.’s EPS increase for this current 12-month fiscal period is 2.70% and is forecasted to reach -0.22 in the upcoming year.
Atossa Therapeutics Inc. (NASDAQ: ATOS) Trading Performance Indicators
Let’s observe the current performance indicators for Atossa Therapeutics Inc. (ATOS). It’s Quick Ratio in the last reported quarter now stands at 85.30. The Stock has managed to achieve an average true range (ATR) of 0.14.
In the same vein, ATOS’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -0.85, a figure that is expected to reach -0.05 in the next quarter, and analysts are predicting that it will be -0.22 at the market close of one year from today.
Technical Analysis of Atossa Therapeutics Inc. (ATOS)
If we take a close look at the recent performances of Atossa Therapeutics Inc. (NASDAQ: ATOS), its last 5-days Average volume was 3.84 million that shows plunge from its year to date volume of 14.13 million. During the previous 9 days, stock’s Stochastic %D was recorded 5.94% While, its Average True Range was 0.1250.
Raw Stochastic average of Atossa Therapeutics Inc. (ATOS) in the period of the previous 100 days is set at 1.09%, which indicates a major fall in contrast to 4.35% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 42.47% that was lower than 66.08% volatility it exhibited in the past 100-days period.